Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy.
Preclinical efforts to discover and develop new drugs and vaccines for tuberculosis are hampered by the reliance on colony-forming unit (CFU) counts as primary outcomes for in vivo efficacy studies and the slow growth of Mycobacterium tuberculosis. The utility of bioluminescent M. tuberculosis repor...
Main Authors: | Tianyu Zhang, Si-Yang Li, Eric L Nuermberger |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3256174?pdf=render |
Similar Items
-
Rapid, serial, non-invasive assessment of drug efficacy in mice with autoluminescent Mycobacterium ulcerans infection.
by: Tianyu Zhang, et al.
Published: (2013-01-01) -
Autoluminescent plants.
by: Alexander Krichevsky, et al.
Published: (2010-01-01) -
Short-time fractal analysis of biological autoluminescence.
by: Martin Dlask, et al.
Published: (2019-01-01) -
Engineering more stable, selectable marker-free autoluminescent mycobacteria by one step.
by: Feng Yang, et al.
Published: (2015-01-01) -
A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis.
by: Stéphane Leung-Theung-Long, et al.
Published: (2018-01-01)